Agus Z S, Puschett J B, Senesky D, Goldberg M
J Clin Invest. 1971 Mar;50(3):617-26. doi: 10.1172/JCI106532.
To evaluate the effects of parathyroid hormone and cyclic adenosine monophosphate on proximal tubular sodium and phosphate reabsorption, micropuncture studies were performed on dogs that received a highly purified preparation of parathyroid hormone (PTH), dibutyryl cyclic 3',5'-adenosine monophosphate (cyclic AMP), 5'-AMP, and saline. PTH resulted in a 30-40% inhibition of sodium and phosphate reabsorption in the proximal tubule unassociated with a rise in either total kidney or single nephron glomerular filtration rate (GFR). The bulk of the phosphate rejected proximally was excreted in the final urine while sodium excretion rose minimally despite the marked proximal inhibition, consistent with the presence of reabsorptive sites in the distal nephron for sodium but not phosphate. The infusion of dibutyryl cyclic AMP either systemically or directly into the renal artery inhibited proximal sodium and phosphate reabsorption in the absence of changes in either total kidney or single nephron GFR, resembling the effects of PTH quantitatively and qualitatively. In contrast, another adenine nucleotide, 5'-AMP, did not inhibit the reabsorption of either sodium or phosphate. These observations support the thesis that renal effects of PTH are mediated via stimulation of renal cortical adenyl cyclase. The infusion of a moderate saline load, 25 ml/kg, also produced a similar inhibition of proximal tubular fractional sodium and phosphate reabsorption with a marked phosphaturia but only minimal natriuresis. Thus, changes in sodium and phosphate reabsorption occur in parallel in the proximal tubule when sodium reabsorption is inhibited either with volume expansion or with administration of "specific" phosphaturic agents such as PTH or cyclic AMP. These data are consistent with the thesis that phosphate reabsorption is dependent upon proximal tubular sodium reabsorption wherein the phosphaturic effect of PTH might be the result of a primary inhibition of proximal tubular sodium reabsorption mediated by adenyl cyclase stimulation.
为评估甲状旁腺激素和环磷酸腺苷对近端肾小管钠和磷酸盐重吸收的影响,对接受高纯度甲状旁腺激素(PTH)、二丁酰环3',5'-腺苷单磷酸(环磷酸腺苷)、5'-腺苷单磷酸和生理盐水制剂的犬进行了微穿刺研究。PTH导致近端肾小管钠和磷酸盐重吸收受到30%-40%的抑制,而总肾或单个肾单位肾小球滤过率(GFR)均未升高。近端被重吸收的大部分磷酸盐在终尿中排出,而尽管近端有明显抑制,但钠排泄仅略有增加,这与远端肾单位存在钠重吸收部位而不存在磷酸盐重吸收部位一致。全身或直接向肾动脉输注二丁酰环磷酸腺苷在总肾或单个肾单位GFR均无变化的情况下抑制近端肾小管钠和磷酸盐重吸收,在数量和质量上类似于PTH的作用。相比之下,另一种腺嘌呤核苷酸5'-腺苷单磷酸并未抑制钠或磷酸盐的重吸收。这些观察结果支持了PTH的肾脏作用是通过刺激肾皮质腺苷酸环化酶介导的这一论点。输注25 ml/kg的适量生理盐水负荷也产生了类似的近端肾小管钠和磷酸盐重吸收分数抑制作用,伴有明显的磷尿,但仅有轻微的利钠作用。因此,当钠重吸收因容量扩张或给予“特异性”排磷剂(如PTH或环磷酸腺苷)而受到抑制时,近端肾小管钠和磷酸盐重吸收的变化是平行发生的。这些数据与磷酸盐重吸收依赖于近端肾小管钠重吸收的论点一致,其中PTH的排磷作用可能是由腺苷酸环化酶刺激介导的近端肾小管钠重吸收的原发性抑制的结果。